423 related articles for article (PubMed ID: 23726443)
1. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores.
Pepe P; Aragona F
Urology; 2013 Jun; 81(6):1142-6. PubMed ID: 23726443
[TBL] [Abstract][Full Text] [Related]
2. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.
Pinkhasov GI; Lin YK; Palmerola R; Smith P; Mahon F; Kaag MG; Dagen JE; Harpster LE; Reese CT; Raman JD
BJU Int; 2012 Aug; 110(3):369-74. PubMed ID: 22313996
[TBL] [Abstract][Full Text] [Related]
3. Acute urinary retention after transperineal template-guided prostate biopsy.
Buskirk SJ; Pinkstaff DM; Petrou SP; Wehle MJ; Broderick GA; Young PR; Weigand SD; O'Brien PC; Igel TC
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1360-6. PubMed ID: 15275721
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of transperineal template-guided prostate biopsy in 409 patients.
Symons JL; Huo A; Yuen CL; Haynes AM; Matthews J; Sutherland RL; Brenner P; Stricker PD
BJU Int; 2013 Sep; 112(5):585-93. PubMed ID: 23551500
[TBL] [Abstract][Full Text] [Related]
5. Complications of transrectal versus transperineal prostate biopsy.
Miller J; Perumalla C; Heap G
ANZ J Surg; 2005; 75(1-2):48-50. PubMed ID: 15740517
[TBL] [Abstract][Full Text] [Related]
6. Transperineal template-guided prostate biopsy: 10 years of experience.
Mai Z; Yan W; Zhou Y; Zhou Z; Chen J; Xiao Y; Liang Z; Ji Z; Li H
BJU Int; 2016 Mar; 117(3):424-9. PubMed ID: 25523314
[TBL] [Abstract][Full Text] [Related]
7. Prostate needle biopsy: 12 vs. 18 cores -- is it necessary?
Pepe P; Aragona F
Urol Int; 2005; 74(1):19-22. PubMed ID: 15711103
[TBL] [Abstract][Full Text] [Related]
8. Morbidity following transperineal prostate biopsy: Our experience in 8.500 men.
Pepe P; Pennisi M
Arch Ital Urol Androl; 2022 Jun; 94(2):155-159. PubMed ID: 35775338
[TBL] [Abstract][Full Text] [Related]
9. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
10. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
[TBL] [Abstract][Full Text] [Related]
11. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen.
Emiliozzi P; Longhi S; Scarpone P; Pansadoro A; DePaula F; Pansadoro V
J Urol; 2001 Sep; 166(3):845-50. PubMed ID: 11490231
[TBL] [Abstract][Full Text] [Related]
12. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
[TBL] [Abstract][Full Text] [Related]
13. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
14. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
[TBL] [Abstract][Full Text] [Related]
15. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity.
Mariappan P; Chong WL; Sundram M; Mohamed SR
BJU Int; 2004 Aug; 94(3):307-10. PubMed ID: 15291857
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre.
Kum F; Jones A; Nigam R
World J Urol; 2019 Feb; 37(2):337-342. PubMed ID: 29974188
[TBL] [Abstract][Full Text] [Related]
17. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
18. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
20. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
